If you've had a heart attack and needed a stent, you know the drill: you leave the hospital with a fistful of medications. This study is asking a big question: what if one of those pills could do the job on its own? Doctors are running a pilot study to see if taking just ticagrelor—a powerful blood thinner—is a safe way to prevent more heart trouble after getting a stent for a heart attack (whether it's the kind called NSTEMI or STEMI). They're enrolling 200 people who have the procedure. The main thing they're watching for is a combination of the worst outcomes: death from heart problems, another spontaneous heart attack, or a blood clot forming in the new stent. They'll track everyone for three months. A special safety board is keeping a close eye on the results, especially after the first 50 people finish the study. The goal is to gather initial safety data on this simpler, one-drug strategy. If it proves safe in this pilot, it could pave the way for larger tests to see if it's just as effective as taking multiple drugs, potentially making recovery simpler for patients.
Can a single blood thinner prevent heart attacks after stent placement?
Photo by Richard R / Unsplash
What this means for you:
A pilot study is checking if one blood thinner is safe to prevent complications after a heart attack stent. More on NSTEMI
Prospective observational study identifies 2,504 potential drug-drug interactions among hospitalized patients with acute coronary syndrome. Heart Patients Face Hidden Risks From Common Drug Mixes
Frontiers · Apr 19, 2026
Ticagrelor Not Noninferior to Prasugrel in Diabetes Patients With Multivessel CAD After PCI New study shows ticagrelor did not beat prasugrel for heart attack prevention in diabetics
JAMA Cardiol · Apr 9, 2026
Adding low-dose rivaroxaban to DAPT did not significantly reduce LV thrombus in anterior STEMI patients. Adding low-dose rivaroxaban to standard heart attack drugs did not clearly prevent blood clots in the heart
JAMA Cardiol · Apr 9, 2026
Lp-PLA2 activity does not significantly modify dual antiplatelet therapy efficacy in minor stroke/TIA with CYP2C19 loss-of-function alleles Blood enzyme levels don't change which stroke prevention drug works better, study finds
· Apr 5, 2026